Allogene Therapeutics Inc (ALLO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 30,309 | 51,688 | 37,815 | 52,332 | 42,455 |
| Marketable Securities | 236,577 | 198,522 | 214,379 | 220,788 | 237,588 |
| TOTAL | $273,293 | $257,749 | $260,719 | $282,655 | $291,576 |
| Non-Current Assets | |||||
| PPE Net | 70,023 | 72,839 | 75,896 | 78,858 | 82,992 |
| Investments And Advances | 0 | 8,043 | 24,944 | 29,510 | 55,506 |
| Other Non-Current Assets | 52,642 | 77,274 | 78,212 | 79,570 | 77,908 |
| TOTAL | $122,665 | $158,156 | $179,052 | $187,938 | $216,406 |
| Total Assets | $395,958 | $415,905 | $439,771 | $470,593 | $507,982 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,933 | 4,270 | 3,699 | 4,851 | 5,058 |
| Accrued Expenses | 23,397 | 28,244 | 28,134 | 26,824 | 24,964 |
| TOTAL | $28,330 | $32,514 | $31,833 | $31,675 | $30,022 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 88,753 | 90,849 | 92,609 | 94,357 | 92,567 |
| TOTAL | $88,753 | $90,849 | $92,609 | $94,357 | $92,567 |
| Total Liabilities | $117,083 | $123,363 | $124,442 | $126,032 | $122,589 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 345,155 | 243,778 | 224,730 | 221,881 | 218,731 |
| Common Shares | 245 | 229 | 223 | 220 | 219 |
| Retained earnings | -2,053,316 | -2,010,709 | -1,971,899 | -1,930,499 | -1,879,556 |
| Other shareholders' equity | -183 | 269 | 235 | -45 | 43 |
| TOTAL | $278,875 | $292,542 | $315,329 | $344,561 | $385,393 |
| Total Liabilities And Equity | $395,958 | $415,905 | $439,771 | $470,593 | $507,982 |